Jeffrey Clarke

机构：Duke Medical Center, Duke Cancer Institute · ORCID：0000-0001-5647-0245

发表论文 206 篇 · 总被引 5016 次 · h-index 28

代表论文

• Symptomatic Necrosis With Dual Immune-Checkpoint Inhibition and Radiosurgery for Brain Metastases (2025 · JAMA Network Open · 被引 20)
• Complement factor H targeting antibody GT103 in refractory non-small cell lung cancer: a phase 1b dose escalation trial (2025 · Nature Communications · 被引 17)
• Updated Overall Survival Analysis From the Phase II PHAROS Study of Encorafenib Plus Binimetinib in Patients With BRAF V600E-Mutant Metastatic Non–Small Cell Lung Cancer (2025 · Journal of Clinical Oncology · 被引 9)
• A Phase II study of GT103 in combination with pembrolizumab in refractory, metastatic non–small cell lung cancer (2025 · Cancer · 被引 3)
• Neoadjuvant, Perioperative, and Adjuvant Immunotherapy in Early-Stage Surgically Resectable Non-Small Cell Lung Cancer: Updates and Future Perspectives. (2025 · Preprints.org · 被引 1)
• MMDA-06 INTRACRANIAL EFFICACY AND TREATMENT BEYOND CNS PROGRESSION WITH TARLATAMAB IN SMALL CELL LUNG CANCER: A MULTI-INSTITUTIONAL REAL-WORLD ANALYSIS (2026 · Neuro-Oncology Advances)